{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T19:00:38Z","timestamp":1745780438227},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11899-009-0030-5","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T07:16:19Z","timestamp":1254294979000},"page":"227-235","source":"Crossref","is-referenced-by-count":15,"title":["Update on the World Health Organization classification of peripheral T-cell lymphomas"],"prefix":"10.1007","volume":"4","author":[{"given":"Hilary M.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"30_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S.H. Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al.: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, edn 4. Lyon, France: International Agency for Research on Cancer; 2008.","edition":"4"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"International T-Cell Lymphoma Project","year":"2008","unstructured":"International T-Cell Lymphoma Project: International Peripheral T-Cell and Natural Killer\/T-Cell Lymphoma Study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"N. Harris","year":"1994","unstructured":"Harris N, Jaffe E, Stein H, et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361\u20131392.","journal-title":"Blood"},{"key":"30_CR4","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","author":"E.S. Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, et al.: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001."},{"key":"30_CR5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"K.J. Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM: Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004, 15:1467\u20131475.","journal-title":"Ann Oncol"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/asheducation-2008.1.280","volume":"2008","author":"K.J. Savage","year":"2008","unstructured":"Savage KJ: Prognosis and primary therapy in peripheral T-cell lymphomas. Hematology 2008, 2008:280\u2013288.","journal-title":"Hematology"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A. Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, et al.: Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004, 103:2474\u20132479.","journal-title":"Blood"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J. Dupuis","year":"2006","unstructured":"Dupuis J, Emile J, Mounier N, et al.: Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood 2006, 108:4163\u20134169.","journal-title":"Blood"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P. Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, et al.: Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006, 24:2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","volume":"25","author":"D. Jong de","year":"2007","unstructured":"de Jong D, Rosenwald A, Chhanabhai M, et al.: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007, 25:805\u2013812.","journal-title":"J Clin Oncol"},{"issue":"Suppl4","key":"30_CR11","first-page":"113a","volume":"19","author":"D.D. Weisenburger","year":"2008","unstructured":"Weisenburger DD, Vose JM, Armitage JO, et al.: Peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic study of 340 cases from the International Peripheral T-Cell Lymphoma Project [abstract]. Ann Oncol 2008, 19(Suppl 4):113a.","journal-title":"Ann Oncol"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B. Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, et al.: Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006, 25:1560\u20131570.","journal-title":"Oncogene"},{"key":"30_CR13","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M. Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES, et al.: Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007, 25:3321\u20133329.","journal-title":"J Clin Oncol"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","volume":"10","author":"B. Martinez-Delgado","year":"2004","unstructured":"Martinez-Delgado B, Melendez B, Cuadros M, et al.: expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 2004, 10:4971\u20134982.","journal-title":"Clin Cancer Res"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"P.P. Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, et al.: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007, 117:823\u2013834.","journal-title":"J Clin Invest"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B. Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, et al.: Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313\u2013318.","journal-title":"Leukemia"},{"key":"30_CR17","first-page":"3","volume":"112","author":"J.W. Friedberg","year":"2008","unstructured":"Friedberg JW, Sharman J, Schaefer-Cutillo J, et al.: Fostamatinib disodium (FosD), an oral inhibitor of syk, is well-tolerated and has significant clinical activity in diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukemia (SLL\/CLL) [abstract 3]. Blood (ASH Annual Meeting Abstracts) 2008, 112:3.","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.20386","volume":"46","author":"C. Thorns","year":"2007","unstructured":"Thorns C, Bastian B, Pinkel D, et al.: Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer 2007, 46:37\u201344.","journal-title":"Genes Chromosomes Cancer"},{"key":"30_CR19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","volume":"164","author":"A. Zettl","year":"2004","unstructured":"Zettl A, Rudiger T, Konrad M, et al.: Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004, 164:1837\u20131848.","journal-title":"Am J Pathol"},{"key":"30_CR20","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N. Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Briere J, et al.: Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood 2008, 111:4463\u20134470.","journal-title":"Blood"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L. Leval de","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, et al.: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109:4952\u20134963.","journal-title":"Blood"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/asheducation-2008.1.272","volume":"2008","author":"L. Leval de","year":"2008","unstructured":"de Leval L, Gaulard P: Pathobiology and molecular profiling of peripheral T-cell lymphomas. Hematology 2008, 2008:272\u2013279.","journal-title":"Hematology"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","volume":"99","author":"A. Attygalle","year":"2002","unstructured":"Attygalle A, Al-Jehani R, Diss TC, et al.: Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002, 99:627\u2013633.","journal-title":"Blood"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","volume":"19","author":"K.L. Grogg","year":"2006","unstructured":"Grogg KL, Attygalle AD, Macon WR, et al.: Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006, 19:1101\u20131107.","journal-title":"Mod Pathol"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/annonc\/mdm579","volume":"19","author":"D. Aguiar Bujanda","year":"2008","unstructured":"Aguiar Bujanda D: Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Ann Oncol 2008, 19:396\u2013397.","journal-title":"Ann Oncol"},{"key":"30_CR26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","volume":"66","author":"H. Stein","year":"1985","unstructured":"Stein H, Mason DY, Gerdes J, et al.: The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66:848\u2013858.","journal-title":"Blood"},{"key":"30_CR27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"S.W. Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, et al.: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 1994, 263:1281\u20131284.","journal-title":"Science"},{"key":"30_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1990.tb02560.x","volume":"74","author":"D.Y. Mason","year":"1990","unstructured":"Mason DY, Bastard C, Rimokh R, et al.: CD30-positive large cell lymphomas (\u2019Ki-1 lymphoma\u2019) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990, 74:161\u2013168.","journal-title":"Br J Haematol"},{"key":"30_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","volume":"8","author":"R. Chiarle","year":"2008","unstructured":"Chiarle R, Voena C, Ambrogio C, et al.: The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 2008, 8:11\u201323.","journal-title":"Nat Rev Cancer"},{"key":"30_CR30","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","volume":"109","author":"L. Lamant","year":"2007","unstructured":"Lamant L, de Reynies A, Duplantier MM, et al.: Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood 2007, 109:2156\u20132164.","journal-title":"Blood"},{"key":"30_CR31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","volume":"140","author":"I. Salaverria","year":"2008","unstructured":"Salaverria I, Bea S, Lopez-Guillermo A, et al.: Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008, 140:516\u2013526.","journal-title":"Br J Haematol"},{"key":"30_CR32","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"K.J. Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, et al.: ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111:5496\u20135504.","journal-title":"Blood"},{"key":"30_CR33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2559.2003.01726.x","volume":"43","author":"R.L. Berge ten","year":"2003","unstructured":"ten Berge RL, de Bruin PC, Oudejans JJ, et al.: ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 2003, 43:462\u2013469.","journal-title":"Histopathology"},{"key":"30_CR34","first-page":"2697","volume":"93","author":"B. Falini","year":"1999","unstructured":"Falini B, Pileri S, Zinzani PL, et al.: ALK+ lymphoma: clinico-pathological findings and outcome. Blood 1999, 93:2697\u20132706.","journal-title":"Blood"},{"key":"30_CR35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","volume":"93","author":"R.D. Gascoyne","year":"1999","unstructured":"Gascoyne RD, Aoun P, Wu D, et al.: Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999, 93:3913\u20133921.","journal-title":"Blood"},{"key":"30_CR36","first-page":"343","volume":"151","author":"S. Pittaluga","year":"1997","unstructured":"Pittaluga S, Wlodarska I, Pulford K, et al.: The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23\/ALK rearrangements. Am J Pathol 1997, 151:343\u2013351.","journal-title":"Am J Pathol"},{"key":"30_CR37","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","volume":"104","author":"I. Bonzheim","year":"2004","unstructured":"Bonzheim I, Geissinger E, Roth S, et al.: Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004, 104:3358\u20133360.","journal-title":"Blood"},{"key":"30_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"W.Y. Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, et al.: Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004, 104:243\u2013249.","journal-title":"Blood"},{"key":"30_CR39","first-page":"265","volume":"13","author":"T. Hongyo","year":"2005","unstructured":"Hongyo T, Hoshida Y, Nakatsuka S, et al.: p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK\/T-cell lymphoma in Korea and Japan. Oncol Rep 2005, 13:265\u2013271.","journal-title":"Oncol Rep"},{"key":"30_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","volume":"160","author":"L.L. Siu","year":"2002","unstructured":"Siu LL, Chan JK, Wong KF, Kwong YL: Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 2002, 160:59\u201366.","journal-title":"Am J Pathol"},{"key":"30_CR41","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/annonc\/mdm183","volume":"18","author":"S. Kim","year":"2007","unstructured":"Kim S, Kim B, Choi C, et al.: Ki-67 expression is predictive of prognosis in patients with stage I\/II extranodal NK\/T-cell lymphoma, nasal type. Ann Oncol 2007, 18:1382\u20131387.","journal-title":"Ann Oncol"},{"key":"30_CR42","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"W. Au","year":"2009","unstructured":"Au W, Weisenburger DD, Intragumtornchai T, et al.: Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009, 113:3931\u20133937.","journal-title":"Blood"},{"key":"30_CR43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","volume":"15","author":"C. Barrionuevo","year":"2007","unstructured":"Barrionuevo C, Zaharia M, Martinez MT, et al.: Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007, 15:38\u201344.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"30_CR44","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/00365520802240222","volume":"43","author":"W.H. Verbeek","year":"2008","unstructured":"Verbeek WH, Van De Water JM, Al-Toma A, et al.: Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol 2008, 43:1322\u20131328.","journal-title":"Scand J Gastroenterol"},{"key":"30_CR45","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"R.J. Deleeuw","year":"2007","unstructured":"Deleeuw RJ, Zettl A, Klinker E, et al.: Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007, 132:1902\u20131911.","journal-title":"Gastroenterology"},{"key":"30_CR46","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/j.1572-0241.2008.02213.x","volume":"103","author":"W.H. Verbeek","year":"2008","unstructured":"Verbeek WH, von Blomberg BM, Scholten PE, et al.: The presence of small intestinal intraepithelial gamma\/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol 2008, 103:3152\u20133158.","journal-title":"Am J Gastroenterol"},{"key":"30_CR47","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A. Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A, et al.: Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002, 161:1635\u20131645.","journal-title":"Am J Pathol"},{"key":"30_CR48","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K. Belhadj","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet JP, et al.: Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003, 102:4261\u20134269.","journal-title":"Blood"},{"key":"30_CR49","doi-asserted-by":"crossref","unstructured":"Moran G, Dillon J, Green J: Crohn\u2019s disease, hepatosplenic Tcell lymphoma and no biological therapy: Are we barking up the wrong tree? Inflamm Bowel Dis 2008 Dec 9 (Epub ahead of print).","DOI":"10.1002\/ibd.20802"},{"key":"30_CR50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.leu.2404168","volume":"20","author":"W.G. Morice","year":"2006","unstructured":"Morice WG, Macon WR, Dogan A, et al.: NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis. Leukemia 2006, 20:883\u2013886.","journal-title":"Leukemia"},{"key":"30_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","volume":"33","author":"I. Wlodarska","year":"2002","unstructured":"Wlodarska I, Martin-Garcia N, Achten R, et al.: Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002, 33:243\u2013251.","journal-title":"Genes Chromosomes Cancer"},{"key":"30_CR52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00428-006-0267-5","volume":"449","author":"J. Tamaska","year":"2006","unstructured":"Tamaska J, Adam E, Kozma A, et al.: Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Virchows Arch 2006, 449:479\u2013483.","journal-title":"Virchows Arch"},{"key":"30_CR53","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","volume":"113","author":"K. Miyazaki","year":"2009","unstructured":"Miyazaki K, Yamaguchi M, Imai H, et al.: Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. Blood 2009, 113:1071\u20131074.","journal-title":"Blood"},{"key":"30_CR54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/10428190601126941","volume":"48","author":"T. Konuma","year":"2007","unstructured":"Konuma T, Ooi J, Takahashi S, et al.: Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma 2007, 48:630\u2013632.","journal-title":"Leuk Lymphoma"},{"key":"30_CR55","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","volume":"111","author":"R. Willemze","year":"2008","unstructured":"Willemze R, Jansen PM, Cerroni L, et al.: Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group study of 83 cases. Blood 2008, 111:838\u2013845.","journal-title":"Blood"},{"key":"30_CR56","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63373-1","volume":"165","author":"M. Lima","year":"2004","unstructured":"Lima M, Almeida J, Montero AG, et al.: Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56\u2212\/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004, 165:1117\u20131127.","journal-title":"Am J Pathol"},{"key":"30_CR57","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1309\/Q49CRJ030L22MHLF","volume":"127","author":"W.G. Morice","year":"2007","unstructured":"Morice WG: The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol 2007, 127:881\u2013886.","journal-title":"Am J Clin Pathol"},{"key":"30_CR58","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R. Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, et al.: WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768\u20133785.","journal-title":"Blood"},{"key":"30_CR59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H. Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, et al.: Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001, 98:280\u2013286.","journal-title":"Blood"},{"key":"30_CR60","first-page":"1165","volume":"24","author":"K. Suzuki","year":"2004","unstructured":"Suzuki K, Ohshima K, Karube K, et al.: Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004, 24:1165\u20131174.","journal-title":"Int J Oncol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0030-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-009-0030-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0030-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:24:46Z","timestamp":1590164686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-009-0030-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s11899-009-0030-5","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}